Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×

We gather, select, interpret and analyze healthcare data from multiple sources to come to accurate, objective business insights ready to implement. Patient flows, customer profiles, information about your key stakeholders and other data related to the market dynamics are translated into forecasting, segmentation and targeting models. With extremely precise methodologies and innovative technologies we assess and visualize your future most successful commercial strategy. Of course, big data analytics is one of our focus areas nowadays. Together with our clients we identify the opportunities around big data in the healthcare industry.

Patient Flow Enabled Forecasting

We design patient flow enabled forecasting models that reliably reflect your future business, at any moment in time. Forecasting based on the results of a thorough market scan and visualized by best-in-class simulation technology. Not just raw data, but insights in the types of patients and the key dynamics that influence and generate your sales. This helps you to effectively identify critical and strategic market dynamics, to allocate marketing investments and to realistically set smart performance targets for your sales teams. Forecasting models are an indispensable tool for market access teams, to quickly visualize different scenarios (e.g. price reduction) and their impact (e.g. physician's prescription behaviour), and thus to prepare negotiations with the government.


Market Dynamic Scan

How to approach new channels? We scan your target markets under dynamic environmental conditions to identify potential growth opportunities. As such, you quickly gain insight in new channels and their specific, competitive mechanisms, however complex they may be. We provide you the necessary knowledge to develop a market-based approach and increase your chances to be successful with new businesses.


mHealth and Big Data in Healthcare

The healthcare industry is still looking for efficient ways to capture market and patient data that is generated through mobile health devices, smartphone apps,etc. and to translate it into crucial business insights. IM Associates looks at what data is needed to answer specific questions, and how that data can best be obtained. Using our statistical competencies, we translate big data in insights that meet your specific requirements. We closely work together with platformproviders that allow secure storage of patient data, and with companies that centralize big data from various healthcare apps and devices.

Discover our approach
download

Segmentation & Targeting

There's an orthodox way of looking at market segmentation and a more innovative one. IM Associates can help you with both. Our approach is driven by your personal preference and goals, the available data, your budget, etc. Ideally, we combine and validate data from multiple sources to come to a quantitative and qualitative segmentation model.


Commercial Structure Assessment

The most adequate commercial structure is drawn with your companies targets and segmentation model in mind. Following a detailed segmentation exercise, we present several possible sales team structures and analyze the pros and cons of the different scenarios. We explicitly take into consideration the future developments and trends we see for the concerned drugs or medical devices. It's an objective assessment of your sales strategy with a measurable impact on your business results.


OTX Alignment

Today's go-to-market models for consumer healthcare products, need to take into account information about pharmacies as well as data from physicians, or ophthalmologists as well as opticians for example. The IM Associates methodology and statistics follow a multi-channel approach in order to interlink all different market players. I.e. we interlink the patients of general practitioners with pharmacies they might visit, or vice versa.


Our analytical services

Customer case

With our patient flow model, we helped a pharma company define the best commercial strategy for its top-selling product, in a context of growing competition. We built a model capable of quickly simulating a 5-years sales impact of several scenarios, taking into account different price strategies, different competitive situations and different cost containment measures. The simulations, combined with transparent and insightful reports, helped our client to get internal approval for a new market access strategy, and to reach a win-win agreement with the authorities.

Featured service

The most adequate commercial structure is drawn with your company's targets and segmentation model in mind. Following a detailed segmentation exercise, we present several possible sales team structures and analyze the pros and cons of the different scenarios. We explicitly take into consideration the future developments and trends we see for the concerned drugs or medical devices. It's an objective assessment of your sales strategy with a measurable impact on your business results.

meet our team of analytical experts

Aline Rosseel

Aline Rosseel

Analyst

Kenneth Naud

Kenneth Naud

Analyst

Romain Liétard

Romain Liétard

Sr Consultant

Anke Beersmans

Anke Beersmans

Consultant

Thomas Euben

Thomas Euben

Team Leader

Philippe Duchateau

Philippe Duchateau

Sr Consultant

discover the entire IM team